Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | SLC18A2 | Q05940 | 1/20 | 0.35 |
| ▸ | NAAA | Q02083 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21103469 | 1.00 | GAA (0.40) | GAAL3MBTL1SLC18A2NAAAKDM4E | |
| SCHEMBL21908621 | 1.00 | GAA (0.40) | GAAL3MBTL1SLC18A2NAAAKDM4E | |
| SCHEMBL21908617 | 1.00 | GAA (0.40) | GAAL3MBTL1SLC18A2NAAAKDM4E | |
| SCHEMBL21908619 | 0.98 | GAA (0.41) | GAAL3MBTL1SLC18A2KDM4E | |
| SCHEMBL21908632 | 0.95 | GAA (0.41) | GAAL3MBTL1SLC18A2 | |
| SCHEMBL21908629 | 0.95 | GAA (0.41) | GAAL3MBTL1SLC18A2 | |
| SCHEMBL21908618 | 0.91 | GAA (0.44) | GAAL3MBTL1SLC18A2 | |
| SCHEMBL21908434 | 0.85 | NAAA (0.30) | NAAA | |
| SCHEMBL21102871 | 0.85 | NAAA (0.30) | NAAA | |
| SCHEMBL21908435 | 0.85 | NAAA (0.30) | NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | DIC CORPORATION (JP) | 2020-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10633590-B2 | Liquid crystal composition and liquid crystal display device including the same | LASP1, UACA, CCDC22 | GAA 4678/4885L3MBTL1 1932/4885SLC18A2 3061/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.